Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-26 @ 4:41 AM
Study NCT ID:
NCT06776757
Status:
RECRUITING
Last Update Posted:
2025-01-15
First Post:
2025-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
Sponsor:
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-25
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-10
First Submit QC Date:
None
Study First Post Date:
2025-01-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-10
Last Update Post Date:
2025-01-15
Last Update Post Date Type:
ACTUAL